Clinical Trials Logo

Medically Unexplained Symptoms clinical trials

View clinical trials related to Medically Unexplained Symptoms.

Filter by:

NCT ID: NCT05666921 Recruiting - Clinical trials for Somatic Symptom Disorder

Alexithymia and Attachment Style in Patients With Somatic Symptoms

Start date: June 15, 2021
Phase:
Study type: Observational

To evaluate whether emotional awareness, attachment style and the ability to abstract and symbolize (IQ) influence the appearance of somatic symptoms. Hypothesis: the investigators expect the presence of somatic symptoms linked to the lower ability of emotional awareness, to lower ability to abstract and symbolize and to an insecure attachment style.

NCT ID: NCT05648123 Completed - Clinical trials for Post-COVID-19 Syndrome

Effectiveness of Supportive Psychotherapy Through Internet-Based Teleconsultation on Psychological and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post Covid-19 Syndrome Patients

Start date: December 21, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the effectiveness of supportive psychotherapy in post covid-19 syndrome patients. The main questions it aims to answer are: 1. What is the effect of supportive psychotherapy on psychological and somatic symptoms in post covid-19 syndrome patients? 2. What is the effect of supportive psychotherapy on the neutrophil lymphocyte ratio in post covid-19 syndrome patients? 3. What is the effect of supportive psychotherapy on heart rate variability in post covid-19 syndrome patients? Participants will be given supportive psychotherapy in the form of an online group for 3 times a week with a duration of psychotherapy ranging from 1 - 2 hours per session. Researchers will compare the supportive psychotherapy group to education group as control. The control group will be given education about Post Covid-19 syndrome in the form of an online group for 3 times a week with a duration of around 1 - 2 hours per session.

NCT ID: NCT05631860 Completed - Fibromyalgia Clinical Trials

Psychological Risk Factors for Functional Somatic Disorders

Start date: November 10, 2011
Phase:
Study type: Observational

The objective of this study is to explore the role of neuroticism, perceived stress, and adverse life events, respectively, in the development and perpetuation of functional somatic disorders.

NCT ID: NCT05620420 Recruiting - Insomnia Clinical Trials

A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma

Start date: November 15, 2022
Phase:
Study type: Observational

Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.

NCT ID: NCT05611606 Completed - Fibromyalgia Clinical Trials

Welfare Benefits in Functional Somatic Disorders

Start date: November 10, 2011
Phase:
Study type: Observational

The objective of this observational study is to estimate the number of weeks of welfare benefits, i.e. sickness benefit, unemployment benefit and social assistance, for individuals with functional somatic disorders and compare them to 1. healthy individuals, and 2. individuals with severe physical disease.

NCT ID: NCT05573919 Recruiting - Airway Obstruction Clinical Trials

VivAer: A Correlation Between Symptom Scores and Objective Findings

Start date: October 7, 2022
Phase: N/A
Study type: Interventional

This is a prospective, single-center study. This study seeks to determine the objective improvement in nasal airflow in patients after undergoing the VivAer procedure, which involves the use of a stylus to deliver controlled and targeted low energy radiofrequency heating (heating by applying high-frequency radio waves) to the nasal sidewall to gently reshape the tissues. Patients who experience refractory, or medically unexplained, nasal obstruction often have symptoms that are not alleviated or resolved by standard non-surgical treatment options. VivAer, a recently developed, FDA-approved procedure, is one of the standard surgical treatments for nasal obstruction. Unlike most of the other established surgical treatments for nasal obstruction, however, VivAer is a minimally-invasive procedure, and it is an outpatient intervention that can be performed under local anesthetic. Eligible patients who are enrolled in the study will undergo the VivAer procedure, and will return to the clinic for three in-office follow-up visits at 4, 12, and 24 weeks after the procedure.

NCT ID: NCT05446766 Completed - Clinical trials for Somatic Symptom Disorder

Feasibility Evaluation of a Self-guided Exposure-based Digital Intervention for Health Anxiety

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

This study investigates the feasibility and preliminary efficacy of a self-guided, exposure-based intervention for individuals who suffer from severe health anxiety. The study is a prospective single-group study based at Karolinska Institutet, Stockholm, Sweden, where 20-25 adults with DSM-5 Illness anxiety disorder or Somatic symptom disorder are enrolled in 8 weeks of unguided exposure-based treatment via the Internet. Outcomes include self-reported health anxiety symptoms, credibility and expectancy, adherence to the treatment protocol, client satisfaction, and negative events.

NCT ID: NCT05225441 Completed - Clinical trials for Psychiatric Disorder

National Investigation in College and High School Among Adolescents on Health and Substances at the FSEF

EnCLASS-FSEF
Start date: March 1, 2022
Phase:
Study type: Observational

For the clinical component: Describe the young people hospitalised in residential care at the FSEF, in particular through vulnerability factors and their psychosocial repercussions (school level, repetition, intensity of symptoms, irritability, nervousness, substance use (cannabis, alcohol, tobacco), social relationships, family relationships, well-being, level of health literacy, learning disorders)) and to compare them with young people from the general school population. For the epidemiological aspect: To study the construct validity of the EnCLASS questions aiming to characterize handicap situations in the general school population in both a population in situation of psychic handicap and of somatic handicap.

NCT ID: NCT05161819 Recruiting - Clinical trials for Somatic Symptom Disorder

Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

Start date: August 29, 2022
Phase: N/A
Study type: Interventional

This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.

NCT ID: NCT05121922 Recruiting - Clinical trials for Medically Unexplained Symptoms

Sense of Coherence and Empowerment at Patients With MUPS

Start date: August 15, 2021
Phase: N/A
Study type: Interventional

This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.